The HERA Foundation Awards Johns Hopkins University Scientists with OS

With funds raised through the HERA Climb4Life series, the HERA Foundation awards three Johns Hopkins University scientists the HERA OSB1 Grant.
Author:
Updated:
Original:

BOULDER, COLO. (March 26, 2009) The HERA Women's Cancer Foundation announces three scientists from Johns Hopkins University in Baltimore, Md. are recipients of its 2009 OSB1 Grant. They include: Drs. Dan Lu, Yuan Tian and Marie-France Penet. OSB1 in an acronym for Ovarian Cancer Seed Bursary grant and also refers to the “Outside-the-Box” thinking the recipients demonstrate in their approach to research new directions in the treatment, prevention and early detection of ovarian cancer. One in 71 women will be diagnosed with ovarian cancer this year. With early detection, more than 90% will survive. Currently, only 24% of ovarian cancer is caught early. 1

The OSB1 grant is awarded annually to Ph.D. and M.D. fellows at Johns Hopkins University and M.D. Anderson Cancer Center at the University of Texas in Houston and is reviewed by an expert panel. Applications are judged based on innovation, science, credentials and significance to ovarian cancer. Since the program's inception in 2003 the HERA Foundation has awarded 16 grants totaling $305,000.

Second-time recipient of the HERA OSB1 grant, Dr. Yuan Tian, 31, received her Ph.D at the China Pharmaceutical University in 2005, followed by a postdoctoral fellowship in Proteomics from the Institute for Systems Biology. Tian joined Johns Hopkins University in 2007 and a year later earned the 2008 Young Investigator Award in Pathology. During Tian's 2008 research, she was able to identify a list of protein markers to discriminate the different subtypes of ovarian cancer and normal ovarian tissue. “This gives us more confidence that our approach is sensitive for identification and quantification of the tumor-specific extracellular proteins that can be potential markers for ovarian cancer prognosis and diagnosis in serum,” says Tian. With the assistance of the HERA Foundation's grant, she hopes to detect subtype-specific glycoproteins from ovarian tumors and evaluate their utilities to help in the prognosis and diagnosis of ovarian cancer.

Dr. Dan Lu, 36, received her medical degree from China Medical University, finished chief-residency training in OB/GYN in 2000, and later earned a Ph.D in Biohcemistry from Ohio State University. During the Ph.D program at OSU, Lu studied under Dr. Tsonwin Hai and focused on the function of ATF3, a stress-induced
gene, during cancer development. Lu was awarded the Ohio State Biochemistry Program fellowship in 2000-2001. Enrolled in Johns Hopkins University since 2006, Lu studied gynecological tumor immunology and
immune evasion under Dr. T.C. Wu. Later Lu studied the identification of new tumor antigens in ovarian cancer under Dr. Richard Roden. Lu's proposed work with funding from the OSB1 grant, aims to develop a more efficient screening methodology to identify cell surface tumor antigens as target therapy of ovarian cancer.

The youngest of the grant recipients, Marie-France Penet, 29, received her Ph.D in Biology from University of Aix-Marseille II in 2005 before she came to Johns Hopkins University. During her stay, she had been working on prostate and breast cancer models for new approaches in imaging techniques. This is her first study with ovarian cancer, and she hope to provide a novel image-guided molecular targeted approach to ovarian cancer treatment.

“This year's recipients represent new directions in science that the HERA Foundation envisioned when first laying the groundwork for the program,” explains Dr. Jill Slansky, principal investigator at University of Colorado Denver and vice president of the HERA Foundation's board. “The OSB1 grant acts as an incubator for these talents and enables young scientists to test novel promising ideas in ovarian cancer research. HERA is honored to be able to support the work of these dynamic and innovative researchers.”

Women who are diagnosed in an early stage have roughly a 90 percent chance of a five-year survival rate. Grants like the OSB1 are important to find new directions in early detection, treatment and prevention to help save women's lives. For more information on the OSB1 grant or the HERA Foundation, please visit www.herafoundation.org.


About the HERA Foundation
The HERA Foundation is a registered 501 (c) 3, whose mission is to stop the loss of mothers, daughters, wives, sisters, partners and girlfriends from ovarian cancer by empowering women to take control of their health, empowering the medical community to find new directions in ovarian cancer research and empowering communities to provide support. For more information, visit www.herafoundation.org.
###

Related

HERA Foundation Announces 2010 Climb4Life Event Schedule

DENVER, COLO. (February 2, 2010) The HERA Women’s Cancer Foundation’s Climb4Life event series is returning in 2010 not only to raise funds for ovarian cancer research, but also to raise awareness around the signs and symptoms of this deadly disease. According to the American ...read more

The HERA Foundation Holds Fourth Annual Climb4Life

CARBONDALE, COLO. (January 19, 2009) The HERA Women's Cancer Foundation joins REI and Black Diamond Climbing Equipment for the fourth annual DC Metro Climb4Life, February 27 to March 28. The month-long event raises money for ovarian cancer research and awareness initiatives ...read more

HERA Foundation Awards Toledo Hospital 2008 Community Grant

(March 21, 2008 — Carbondale, CO) The Toledo Hospital (TTH) is one of four 2008 HERA Foundation Community Grant recipients and will receive $1,000 for its new massage pilot program for ovarian cancer patients. TTH will collaborate with the Victory Center, a local non-profit ...read more

The HERA Foundation Presents the Susan Sandoval Ovarian Cancer Run

Salt Lake City, UT. (July 16, 2009) September is Ovarian Cancer Awareness month and in Salt Lake City, several organizations are joining forces to aid in the fight against ovarian cancer by creating awareness of symptoms, risk factors and raising funds for innovative research. On ...read more

Numbers are Up and Rising for HERA Foundation’s Climb4Life DC Metro

CARBONDALE, COLO. (March 6, 2009) The economy may be down, but for the HERA Women's Cancer Foundation's DC Metro Climb4Life event, the numbers are up and rising. The month-long fundraising event kicked off Friday, February 27 at REI in Fairfax, Va. with 430 registered ...read more

Montrail Awards HERA Foundation Give Back Grant

CARBONDALE, COLO. Montrail, a leading brand in the outdoor industry, awarded the HERA Women's Cancer Foundation the Montrail Gives Back Grant. The grant program is 100 percent employee-driven and aims to support the places, people and organizations that that protect the outdoors ...read more

HERA Foundation Partners with Cycling Event Producer Swagger

September is Ovarian Cancer Awareness Month, and two prestigious cycling events in Las Vegas will be raising awareness of the disease, as well as funds for the HERA Women's Cancer Foundation. Swagger, the Georgia-based cycling event–production company responsible for the USA ...read more

HERA Climb4Life Metro D.C. Raises Over $60,000

CARBONDALE, COLO. (April 16, 2009) In a challenging economy, the HERA Foundation continues to gain momentum in its fight against ovarian cancer. The non-profit's Fourth Annual Climb4Life Metro D.C., held February 27 to March 28, 2009, raised just over $60,000 for its ovarian ...read more

Petzl's John Evans Receives HERA Foundation’s Power of One Award

CONTACT:Justin Roth, Petzl America 801/926-1500 jroth@petzl.comCLEARFIELD, Utah (September 25th, 2012) – Petzl America's Marketing Director John Evans is being honored by the HERA foundation's Power of One award for 2012. The award recognizes one company or individual annually ...read more